Questions and answers on comparability considerations for advanced therapy medicinal products (ATMP) - Scientific guideline
HumanAdvanced therapies
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document addresses questions on how to demonstrate comparability for gene and cell-based medicinal products following change to the manufacturing process or due to introduction of additional manufacturing sites.
Keywords: Gene therapy medicinal products; cell-therapy and tissue engineering.